Viewing Study NCT01163292

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:37 PM

Ignite Modification Date: 2025-12-26 @ 11:01 AM

Study NCT ID: NCT01163292

Status: COMPLETED

Last Update Posted: 2018-07-06

First Post: 2010-07-14

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))

Sponsor: AbbVie (prior sponsor, Abbott)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module